BrainEver
Latest round
- Series B
Last raised
- Jul 2025
Total raised
- $39M
Investors
- 3
About BrainEver
Founded in 2015 in Paris, France, BrainEver SAS is engaged in biotechnology focused on treating neurodegenerative conditions.BrainEver is focused on developing innovative therapies targeted at halting the progression of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Parkinson's disease, and age-related retinal diseases. The company's core offerings are centered around the use of Homeoproteins, which are identified as specific factors for neuron maintenance and rejuvenation. These therapies aim to stop neuronal death while durably modifying the physiology and metabolism of surviving neurons, addressing significant unmet medical needs within the healthcare sector. BrainEver's products are being developed for clinical use, with a specific focus on European markets, where there is a substantial demand for effective treatments for these debilitating conditions.BrainEver's revenue model is built around partnerships and collaborations with various stakeholders in the biopharmaceutical industry, including academic institutions and healthcare organizations.5 mn from the European Innovation Council, which supports its research into Homeoproteins as novel therapies. This model is particularly relevant as BrainEver progresses its drug candidates toward clinical trials and eventual market introduction. The company is focused on developing new therapies targeting ALS and Parkinson's disease, with plans for clinical trial launches in the coming two years.
Who invested in BrainEver
3 investors across 1 round
See all investors in BrainEver
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 15, 2025
Amount
$39M
Investors
Questions about BrainEver
Who invested in BrainEver?
BrainEver has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BrainEver raised?
BrainEver has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BrainEver last raise money?
BrainEver's most recent round on record is a Series B, in Jul 2025.
What does BrainEver do?
Founded in 2015 in Paris, France, BrainEver SAS is engaged in biotechnology focused on treating neurodegenerative conditions.
Where is BrainEver headquartered?
BrainEver is headquartered in Paris, France.
Which VCs invest in companies like BrainEver?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at BrainEver's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like BrainEver? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.